Skip to main content
SpringerLink
Log in

Niedermolekulares Heparin senkt Thromboserisiko bei chemotherapeutisch behandelten Tumorpatienten

Low molecular weight heparin decreases thrombosis risk in patients receiving chemotherapy for cancer

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Borsig LL (2009) Heparin as an inhibitor of cancer progression. Prog Mol Biol Transl Sci 93:335–349

    Article  Google Scholar 

  2. Agnelli G, George DJ, Kakkar AK et al (2012) Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med 366:601–609

    Article  PubMed  CAS  Google Scholar 

  3. Akl EA, Gunukula S, Barba M et al (2011) Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation. Cochrane Database Syst Rev CD006652

  4. Akl EA, Schünemann HJ (2012) Routine heparin for patients with cancer? One answer, more questions. N Engl J Med 366:661–662

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikte

Es bestehen für beide Autoren keine Interessenkonflikte mit dem Studiensponsor Sanofi.

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Universitätsklinikum „Carl Gustav Carus“ an der Technischen Universität Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland

    S. Heller &  M. Krause

Authors
  1. S. Heller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Krause
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to S. Heller or M. Krause.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heller, S., Krause, M. Niedermolekulares Heparin senkt Thromboserisiko bei chemotherapeutisch behandelten Tumorpatienten. Strahlenther Onkol 189, 514–515 (2013). https://doi.org/10.1007/s00066-013-0352-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-013-0352-z

Search

Navigation